Preparation of self-microemulsifying semi-solid matrix hard capsules of cyclosporine A;

In Vitro study of the effect of cyclosporine A,tetrandrine and their combination on the reversion of multidrug resistance in leukemia cell line;

General physiologically pharmcokinetics model of cyclosporine A;

Comparison between cyclosporine and glucocorticoid in treatment of oral lichen planus:a systematic review

Diazoxide and Cyclosporine A inhibits cultured primitive rat basal forebrain cholinergic neuron apoptosis induced by Aβ_(1-42)

OBJECTIVE To construct a population pharmacokinetic model for cyclosporine, which was constructed by NONMEM, and to adjust administration individually.

Clinical observation of cyclosporin A in treatment of severe ulcerative colitis;

Effects of combination of Genistein with Cyclosporin A on immune response of mouse lymphocytes in vitro;

Effect of cyclosporin A on sorcin gene expression and clinical effect in multiple myeloma patients;

Investigation of Drug Resistance of Monilia to Fluconazole and 5-fluocytosine and the Synergistic Effect of Fluconazole and Cyclosporin in Vitro;

Objective To investigate the clinical effect of cyclosporin A(CsA) as a reversal agent associated with classical chemotheraphy to reverse multidrug resistance(MDR) in refractory acute leukemia(RAL).

Objective To observe the therapeutic effect of TCM syndrome-typing based therapy(TCM-STBT)combined with cyclosporin on myelodysplastic syndrome(MDS)and investigate the correlation of efficacy with TCM syndrome type and MDS type.

The purpose of study was to evaluate the effect of stopping use of cyclosporine A(CsA)in reversion of donor chimeras of chronic myeloid leukemia(CML)patients relapsed after transplantation.

The present study was to investigate the mRNA, protein expression and the activity of calci-neurin in the hypertrophic heart, and to determine the effect of calcineurin inhibitor —— cyclosporine A(CsA) on the regression of cardiac hypertrophy in renovascular hypertensive rats.